VEGFA and age-related macular degeneration: Although initial studies in this area have assessed the cytokine profiles of AMD patients pre- and post-treatment and in comparison to non-disease patients, little is known about cytokine changes over the course of anti-VEGF treatment at the initial loading dose stages or the correlation with anatomical outcomes.12